molnupiravir

Molnupiravir: From Press Release to Practice

Yesterday (10/01/21 for historical context), there was quite a stir after a press release by Merck Pharmaceuticals after reports that their new antiviral medication, molnupiravir. They claim it shows benefits in early COVID-19. In this post, I plan on updating the newest data that comes out regarding this medication using real data. For now, all …

Continue reading Molnupiravir: From Press Release to Practice

Pain management

Non-opioid Pain/Sedation Management in the ICU

There's a lecture that I have shared with audiences looking at opioid-sparing medications for pain and sedation in the intensive care unit that I have been working on for several years. In this post, I will be sharing this content with you all with the citations you everyone can better their practices and we can …

Continue reading Non-opioid Pain/Sedation Management in the ICU

baricitinib covid

Baricitinib: Suppressing the Inflammation in COVID Patients

Now that tocilizumab is so difficult to obtain (written on 9/2/21 and obviously subject to change), we need another therapy to help improve outcomes in patients with COVID-19 who are hospitalized and critically ill. Baricitinib has entered the chat. Wow, I am all full of stupid meme references these days. Baricitinib is a Janus kinase …

Continue reading Baricitinib: Suppressing the Inflammation in COVID Patients

COVID-19 & Proton Pump Inhibitors (PPI): Are they Friends or Foes?

Here are some of the issues with COVID-19 patients when they are hospitalized. First, they receive high doses of corticosteroids which have an association to GI bleeds. Second, they are (in some institutions) receiving full-dose anticoagulation with heparin, enoxaparin, or a DOAC. This has led many to just go ahead and pull the trigger on …

Continue reading COVID-19 & Proton Pump Inhibitors (PPI): Are they Friends or Foes?

Pregnancy and Severe COVID-19: Separating the Facts from the Fiction

I have been asked about pregnancy and COVID-19 on numerous occasions and I have deferred answering the question because I honestly had not looked much into it. Recently, I was challenged with the task and have stepped up to the occasion of looking into the data of how pregnancy is affected by COVID-19. These are …

Continue reading Pregnancy and Severe COVID-19: Separating the Facts from the Fiction

expectations covid

Expectations for Families of COVID-19 Patients on the Ventilator

On 8/9/21 I put out a tweet discussing (in a certain limited number of characters) how difficult it is to get a patient who is intubated and placed on mechanical ventilation because of severe COVID-19 ARDS. I used the analogy of landing an airplane in a hurricane. Definitely not easy. Something came over me where …

Continue reading Expectations for Families of COVID-19 Patients on the Ventilator

Driving Pressure in ARDS: Improving Survival By Any Means Necessary

Patients placed on mechanical ventilation carry a certain mortality by default. Obviously it is not a good thing to end up intubated in the ICU. It's one thing to set up a patient on mechanical ventilation and then just twist the knobs to get a pretty arterial blood gas that's satisfactory to keep the patient …

Continue reading Driving Pressure in ARDS: Improving Survival By Any Means Necessary

obesity covid

Obesity in Critical Illness & COVID-19: A Very Bad Combination

This is a difficult subject to discuss because we all have people we love who suffer from issues that have led to them having a higher weight than what they should and, in turn, carry the diagnosis of obesity. This post is not intended to shame anyone. But there's definitely a link between obesity and …

Continue reading Obesity in Critical Illness & COVID-19: A Very Bad Combination

ttm

Hypothermia (33°C) vs. Normothermia (37.5°C) in Cardiac Arrest – TTM2

Way back when I was just a baby intern, I remember placing these large IJ cannulas in the patients who suffered cardiac arrests to proceed with hypothermia. Later in my training, in December of 2013, the NEJM published the Targeted Temperature Management (TTM trial) looking at 33°C versus 36°C after Cardiac Arrest. The paradigm began …

Continue reading Hypothermia (33°C) vs. Normothermia (37.5°C) in Cardiac Arrest – TTM2

ICU COVID-19 Patients Don’t Get Well Soon, Unfortunately

Those of us who have placed COVID-19 ICU patients on mechanical ventilation know that this is not a process that is going to resolve overnight. Patient with decompensated congestive heart failure with pulmonary edema? Better in 24-48 hours. Aspiration pneumonia in a young kid who partied a little too hard? Better in a few days. …

Continue reading ICU COVID-19 Patients Don’t Get Well Soon, Unfortunately